Elite Pharmaceuticals, Inc.
ELTP
$0.26
$0.00-1.08%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.68% | 41.26% | -20.75% | 22.45% | 92.11% |
| Total Receivables | -15.53% | 23.05% | 18.74% | 12.85% | 24.01% |
| Inventory | 13.83% | -15.30% | 38.17% | -6.16% | 19.19% |
| Prepaid Expenses | -32.07% | -35.48% | 1,381.22% | -74.54% | -43.89% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.12% | 15.82% | 12.82% | 10.19% | 34.85% |
|
|
|||||
| Total Current Assets | 2.12% | 15.82% | 12.82% | 10.19% | 34.85% |
| Net Property, Plant & Equipment | 2.43% | -0.72% | -2.25% | -2.95% | -2.06% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -100.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -10.00% | -18.83% | -8.61% | -8.34% | -20.12% |
| Total Assets | 1.00% | 9.40% | 7.82% | 5.31% | 15.51% |
|
|
|||||
| Total Accounts Payable | -7.63% | -7.19% | 90.45% | -32.70% | 72.06% |
| Total Accrued Expenses | -44.05% | 102.30% | -19.35% | 53.70% | 10.82% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.39% | 2.37% | 1.89% | 0.62% | 0.71% |
| Total Finance Division Other Current Liabilities | 2,981.15% | -25.94% | 199.03% | -64.49% | 118.26% |
| Total Other Current Liabilities | 2,981.15% | -25.94% | 199.03% | -64.49% | 118.26% |
| Total Current Liabilities | 75.04% | 31.88% | 23.55% | -0.83% | -9.10% |
|
|
|||||
| Total Current Liabilities | 75.04% | 31.88% | 23.55% | -0.83% | -9.10% |
| Long-Term Debt | -0.72% | -0.73% | -0.70% | -5.62% | -0.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.40% | -11.70% | -10.22% | -8.39% | -8.16% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -38.00% | -29.70% | -15.89% | 87.74% |
| Total Liabilities | -11.58% | -14.52% | -17.18% | -12.56% | 48.48% |
|
|
|||||
| Common Stock & APIC | 0.02% | 0.06% | 0.08% | 0.11% | 0.03% |
| Retained Earnings | 7.79% | 19.58% | 16.47% | 10.82% | -4.88% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 6.01% | 23.12% | 30.41% | 29.16% | -10.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.01% | 23.12% | 30.41% | 29.16% | -10.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.01% | 23.12% | 30.41% | 29.16% | -10.90% |
|
|
|||||